Roche CEO Thomas Schinecker joins Bloomberg's "The Opening Trade" to discuss his company's earnings and the timeline for the potential launch for Roche's blockbuster breast cancer pill that may become one of the company's biggest sellers by the end of the year.

Senior Fellow at Council on Foreign Relations Rebecca Patterson Talks "Too Much"
07:54

Chief Economist at New Century Advisors Claudia Sahm Talks Labor Market
08:57

NEC Director Kevin Hassett Talks US Debt
09:38